Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

527.06
-17.9400-3.29%
Volume:234.81K
Turnover:125.21M
Market Cap:22.61B
PE:18.86
High:545.00
Open:545.00
Low:524.79
Close:545.00
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.45
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.53
PE(LYR):18.92

Loading ...

United Therapeutics Corporation Announces FDA Approval of the Lungfx™ Device for Centralized Ex Vivo Lung Perfusion

THOMSON REUTERS
·
Jun 29

United Therapeutics CEO Martine Rothblatt Disposes of USD 4.99 Million in Common Shares

Reuters
·
Jun 26

United Therapeutics Chairperson and CEO Martine Rothblatt Disposes of Common Shares Worth $5.08 Million

Reuters
·
Jun 24

United Therapeutics CFO James Edgemond sells 8,750 shares worth $4.7 million

Reuters
·
Jun 24

United Therapeutics CEO Martine Rothblatt disposes of 11,480 common shares worth $6.19 million

Reuters
·
Jun 23

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 5.19 million in common shares

Reuters
·
Jun 18

United Therapeutics CFO, Treasurer James Edgemond disposes of USD 9.12 million in common shares

Reuters
·
Jun 17

United Therapeutics Chairperson, CEO Martine Rothblatt sells $4.9 million in common shares

Reuters
·
Jun 16

United Therapeutics CFO James Edgemond disposes of common shares worth $5.42 million

Reuters
·
Jun 13

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of common shares worth $5.17 million

Reuters
·
Jun 13

Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)

TIPRANKS
·
Jun 12

United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 8,500 common shares worth $4.65 million

Reuters
·
Jun 12

United Therapeutics CFO James Edgemond disposes of USD 5.47 million in common shares

Reuters
·
Jun 10

United Therapeutics CEO Chairperson Martine Rothblatt disposes of common shares worth $5.2 million

Reuters
·
Jun 10

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.19 million

Reuters
·
Jun 09

United Therapeutics CFO James Edgemond disposes of 8,000 shares worth $4.36 million

Reuters
·
Jun 06

United Therapeutics Chairperson and CEO Martine Rothblatt reports UTHR share disposal worth $4.25 million

Reuters
·
Jun 06

Will Positive TETON-1 IPF Data and Space R&D Shift United Therapeutics' (UTHR) Innovation Narrative?

Simply Wall St.
·
Jun 06

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Fate Therapeutics (FATE) and Edgewise Therapeutics (EWTX)

TIPRANKS
·
Jun 06

United Therapeutics EVP, General Counsel Paul A. Mahon disposes of common shares worth $4.68 million

Reuters
·
Jun 05